Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Anti-proliferative effect of Klimaktoplan® on human breast cancer cells.

Ahn KH, Yi KW, Park HT, Shin JH, Hur JY, Kim SH, Kim T.

Arch Gynecol Obstet. 2013 Oct;288(4):833-8. doi: 10.1007/s00404-013-2849-1.

PMID:
23595584
2.

The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.

Krämer EA, Seeger H, Krämer B, Wallwiener D, Mueck AO.

Eur J Obstet Gynecol Reprod Biol. 2006 Nov;129(1):77-83.

PMID:
16460873
4.

Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.

Neubauer H, Ruan X, Schneck H, Seeger H, Cahill MA, Liang Y, Mafuvadze B, Hyder SM, Fehm T, Mueck AO.

Menopause. 2013 May;20(5):504-10. doi: 10.1097/GME.0b013e3182755c97.

PMID:
23615641
5.

Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.

Courtin A, Communal L, Vilasco M, Cimino D, Mourra N, de Bortoli M, Taverna D, Faussat AM, Chaouat M, Forgez P, Gompel A.

Breast Cancer Res Treat. 2012 Jan;131(1):49-63. doi: 10.1007/s10549-011-1394-5.

PMID:
21336598
6.

Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.

Schneck H, Ruan X, Seeger H, Cahill MA, Fehm T, Mueck AO, Neubauer H.

Gynecol Endocrinol. 2013 Feb;29(2):160-3. doi: 10.3109/09513590.2012.730572.

PMID:
23116217
7.

The presence of a membrane-bound progesterone receptor sensitizes the estradiol-induced effect on the proliferation of human breast cancer cells.

Neubauer H, Yang Y, Seeger H, Fehm T, Cahill MA, Tong X, Ruan X, Mueck AO.

Menopause. 2011 Aug;18(8):845-50. doi: 10.1097/gme.0b013e31820e5ac5.

PMID:
21532513
9.
10.

Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.

Chen FP, Chien MH, Chen HY, Huang TS, Ng YT.

Taiwan J Obstet Gynecol. 2013 Sep;52(3):365-73. doi: 10.1016/j.tjog.2012.09.038.

11.

Influence of marketed herbal menopause preparations on MCF-7 cell proliferation.

Bodinet C, Freudenstein J.

Menopause. 2004 May-Jun;11(3):281-9.

PMID:
15167307
13.
14.

Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1.

Zhou J, Yu Q, Chen R, Seeger H, Fehm T, Cahill MA, Mueck AO, Neubauer H.

Maturitas. 2013 Oct;76(2):129-33. doi: 10.1016/j.maturitas.2013.06.013.

PMID:
23856385
15.

Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.

Werner HM, Franke HR, Vermes I.

Climacteric. 2005 Sep;8(3):294-9.

PMID:
16390761
16.

Anti-proliferative effects of homeopathic medicines on human kidney, colon and breast cancer cells.

Arora S, Aggarwal A, Singla P, Jyoti S, Tandon S.

Homeopathy. 2013 Oct;102(4):274-82. doi: 10.1016/j.homp.2013.06.001.

PMID:
24050774
19.

Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.

Wood CE, Register TC, Lees CJ, Chen H, Kimrey S, Cline JM.

Breast Cancer Res Treat. 2007 Jan;101(2):125-34.

PMID:
16841178
20.

Influence of Cimicifuga racemosa on the proliferation of estrogen receptor-positive human breast cancer cells.

Bodinet C, Freudenstein J.

Breast Cancer Res Treat. 2002 Nov;76(1):1-10.

PMID:
12408370

Supplemental Content

Support Center